Status:
COMPLETED
Soft Tissue Width and Abutment Height Influence Peri-implant Bone Resorption
Lead Sponsor:
International Piezosurgery Academy
Conditions:
Alveolar Bone Loss
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this clinical and radiographic study will be to determine what influence on marginal bone loss has the thickness of soft tissues and the height of the prosthetic abutment and eventually...
Detailed Description
The purpose of this clinical and radiographic study will be to determine what influence on marginal bone loss has the thickness of soft tissues and the height of the prosthetic abutment and eventually...
Eligibility Criteria
Inclusion
- General inclusion criteria were:
- age\>18 years;
- good general health;
- non smokers;
- absence of systemic diseases affecting bone metabolism and wound healing; - no regular medication consumption for at least 3 months prior to treatment; - patient willing and fully capable to comply with the study protocol;
- written informed consent given.
- Local inclusion criteria were:
- presence of keratinized mucosa with a minimum bucco-lingual width of 3 mm; - bone crest with at least 6 mm of width and 9 mm of height above the mandibular canal, without concomitant or previous bone augmentation procedures;
- presence of the opposing dentition.
- Exclusion criteria were:
- history of head or neck radiation therapy;
- uncontrolled diabetes (HBA1c \>7.5%);
- active infections;
- immunocompromised patients (HIV infection or chemotherapy within the past 5 years);
- present or past treatment with intravenous bisphosphonates;
- patient pregnancy or lactating at any time during the study;
- poor oral hygiene and motivation;
- untreated periodontal disease;
- psychological or psychiatric problems;
- alcohol or drugs abuse;
- participating in other studies, if the present protocol could not be properly followed;
- lack of implant primary stability.
Exclusion
Key Trial Info
Start Date :
May 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2019
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03229005
Start Date
May 15 2017
End Date
June 15 2019
Last Update
August 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Piezosurgery Academy
Parma, PR, Italy, 43100